Rules coming into force aim to better shield sensitive industrial sectors from Chinese and other foreign investors, as political pushback on overseas acquisitions of strategic assets heats up
US biomedical research body has seen its role grow during the pandemic but has found itself in dispute with the US president. ‘Trump was forced on BARDA, not the other way around’, says one observer
Reinhard Bütikofer is wary of the growing power of China and the reach of companies seen as beholden to the Communist government. His views are typical of the more hawkish approach emerging in Brussels
The pandemic has ‘fast-tracked conversations’ about online learning and R&D, says University of Cape Town vice-chancellor. But despite a few positive forces unleashed by the virus, South Africa is facing many negatives
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.